Ligand Pharmaceuticals Incorporated
Status: Publicly traded
Direct answer
Ligand Pharmaceuticals Incorporated is publicly traded on NASDAQ under the ticker LGND.
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both...
Can you invest in Ligand Pharmaceuticals Incorporated?
Yes. Ligand Pharmaceuticals Incorporated is publicly traded on NASDAQ under the ticker LGND.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ligand Pharmaceuticals Incorporated
Detailed equity research is provided by MarketSnap.